Ignite Creation Date:
2024-05-06 @ 4:23 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04969731
Status:
RECRUITING
Last Update Posted:
2021-11-22
First Post:
2021-07-06
Brief Title:
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Sponsor:
GC Cell Corporation
Organization:
GC Cell Corporation
Organization Data
Organization:
GC Cell Corporation
Class:
INDUSTRY
Study ID:
ILC-P3-PAN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GC Cell Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None